These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9350)

  • 41. Characterization of the proteinase inhibitors from bull seminal plasma and spermatozoa.
    Cechová D; Fritz H
    Hoppe Seylers Z Physiol Chem; 1976 Mar; 357(3):401-8. PubMed ID: 133981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study.
    Casale E; Collyer C; Ascenzi P; Balliano G; Milla P; Viola F; Fasano M; Menegatti E; Bolognesi M
    Biophys Chem; 1995 Mar; 54(1):75-81. PubMed ID: 7703351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anatomical relationship between kallikrein-containing tubules and the juxtaglomerular apparatus in the human kidney.
    Vio CP; Figueroa CD; Caorsi I
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):269-71. PubMed ID: 3390319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and characterization of rat urinary esterase A1.
    Nakamura M; Takaoka M; Nishii M; Morimoto S
    Biochim Biophys Acta; 1986 Nov; 884(2):311-8. PubMed ID: 3094589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous kallikrein inhibitor in rat kidney cortex-effect of glucocorticoid administration.
    Ito K; Yamada K; Yoshida S; Hasunuma K; Tamura Y; Yoshida S
    Adv Exp Med Biol; 1986; 198 Pt A():361-5. PubMed ID: 3643717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The major plasma kallikrein inhibitor of guinea pig plasma.
    Imamura T; Kambara T
    Biochim Biophys Acta; 1992 Feb; 1118(3):261-6. PubMed ID: 1737048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An inactive form of kallikrein in human urine.
    Kizuki K; Shimamoto Y; Ikekita M; Moriya H
    Adv Exp Med Biol; 1986; 198 Pt A():329-37. PubMed ID: 3544716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa.
    Shibata T; Ogawa M; Matsuda K; Miyauchi K; Yamamoto T; Mori T
    Clin Chim Acta; 1986 Aug; 159(1):27-36. PubMed ID: 3638992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
    Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
    Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kallikrein and prekallikrein on the basolateral membrane of rat kidney tubules.
    Yamada K; Schulz WW; Page DS; Erdös EG
    Hypertension; 1981; 3(6 Pt 2):II-59-64. PubMed ID: 6271673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension.
    Shimamoto K; Masuda A; Ando T; Ura N; Nakagawa M; Mori Y; Nakagawa H; Sakakibara T; Ogata H; Iimura O
    Hypertension; 1989 Oct; 14(4):375-8. PubMed ID: 2676859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and characterization of canine urinary kallikrein.
    Murthy KK; Carretero OA; Scicli AG
    Arch Biochem Biophys; 1986 Feb; 244(2):563-71. PubMed ID: 2418786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of porcine glandular kallikreins by structurally homologous proteinase inhibitors of the Kunitz (Trasylol) type. Significance of the basic nature of amino acid residues in subside positions for kallikrein inhibition.
    Dietl T; Huber C; Geiger R; Iwanaga S; Fritz H
    Hoppe Seylers Z Physiol Chem; 1979 Jan; 360(1):67-71. PubMed ID: 761847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and characterization of rat plasma glandular kallikrein.
    Masferrer J; Albertini R; Croxatto HR; García P; Pinto I
    Biochem Pharmacol; 1985 Jan; 34(1):51-6. PubMed ID: 3843928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of native and [homoserine lactone-52]-52,53-seco-bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to porcine pancreatic beta-kallikrein-B and bovine alpha-chymotrypsin: thermodynamic study.
    Oddone R; Barra D; Amiconi G; Ascenzi P; Tarricone C; Bolognesi M; Bortolotti F; Menegatti E
    J Mol Recognit; 1994 Mar; 7(1):39-46. PubMed ID: 7527234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification of cat submaxillary kallikrein.
    Fukuoka Y; Hojima Y; Miyaura S; Moriwaki C
    J Biochem; 1979 Feb; 85(2):549-57. PubMed ID: 422546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical characterization and substrate specificity of rat prostate kallikrein (S3): comparison with tissue kallikrein, tonin and T-kininogenase.
    Wang C; Tang CQ; Zhou GX; Chao L; Chao J
    Biochim Biophys Acta; 1992 Jun; 1121(3):309-16. PubMed ID: 1320938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inhibition of porcine pancreas kallikrein by di-isopropyl-fluorophosphate. Kinetics, stoichiometry, and nature of the group phosphorylated.
    Fiedler F; Müller B; Werle E
    Eur J Biochem; 1969 Oct; 10(3):419-25. PubMed ID: 5388498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.